DR. REDDY S LABORATORIES Quarterly Results (DRREDDY) — Q2 FY27
DR. REDDY S LABORATORIES reported revenue of ₹8,671 cr and net profit of ₹925 cr in Q2 FY27 (quarter ended 30 Sept 2026), -35.6% year on year. Below is the full quarter-wise results table with revenue, operating profit, margins, tax, EPS and annual history — updated when Yahoo Finance publishes updated financial statements; exchange filings can appear earlier.
DR. REDDY S LABORATORIES Q2 FY27 key results metrics
Quarter
Q2 FY27
Quarter ended
30 Sept 2026
Revenue
₹8,671 cr
Revenue YoY
-1.5%
Operating profit
₹1,281 cr
Operating margin
14.8%
Net profit
₹925 cr
Net profit YoY
-35.6%
Net profit QoQ
+108.6%
Net margin
10.7%
Basic EPS
₹11.11
TTM revenue
₹32,984 cr
TTM net profit
₹2,799 cr
TTM net margin
8.5%
DRREDDY Q2 FY27 results: what the numbers say
DR. REDDY S LABORATORIES (DRREDDY) has reported its Q2 FY27 results for the quarter ended 2026-09-30. The company posted revenue of ₹8,671 cr and a net profit of ₹925 cr, translating into earnings per share of ₹11.11.
Compared with the same quarter a year earlier, revenue declined marginally by -1.5% and net profit declined strongly by -35.6%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹1,281 cr, an operating margin of 14.8% versus 20.6% a year ago — a contraction of 5.9 percentage points.
DRREDDY quarter-wise results table
Revenue
₹8,671 cr
-1.5%YoY
Net profit
₹925 cr
-35.6%YoY
Operating profit
₹1,281 cr
-29.5%YoY
EPS
₹11.11
—YoY
DR. REDDY S LABORATORIES (DRREDDY) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth
Quarter
Revenue
Operating profit
Net profit
OPM
Net margin
EPS
Profit YoY
Profit QoQ
Q2 FY272026-09-30
₹8,671 cr
₹1,281 cr
₹925 cr
14.8%
10.7%
₹11.11
-35.6%
+108.6%
Q1 FY272026-06-30
₹8,071 cr
₹303 cr
₹444 cr
3.8%
5.5%
₹5.32
—
+100.8%
Q4 FY262026-03-31
₹7,516 cr
₹82.9 cr
₹221 cr
1.1%
2.9%
₹2.65
—
-81.7%
Q3 FY262025-12-31
₹8,727 cr
₹1,433 cr
₹1,210 cr
16.4%
13.9%
₹14.53
—
-15.8%
Q2 FY262025-09-30
₹8,805 cr
₹1,818 cr
₹1,437 cr
20.6%
16.3%
—
—
—
TTM (last 4 quarters)
₹32,984 cr
₹3,100 cr
₹2,799 cr
9.4%
8.5%
₹33.61
—
—
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
DRREDDY quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
DR. REDDY S LABORATORIES quarterly income statement
Particulars
Q2 FY272026-09-30
Q1 FY272026-06-30
Q4 FY262026-03-31
Q3 FY262025-12-31
Q2 FY262025-09-30
Revenue / Sales
₹8,671 cr
₹8,071 cr
₹7,516 cr
₹8,727 cr
₹8,805 cr
Total expenses
₹7,390 cr
₹7,767 cr
₹7,433 cr
₹7,294 cr
₹6,988 cr
Gross profit
₹4,520 cr
₹3,754 cr
₹4,304 cr
₹4,681 cr
₹4,814 cr
Operating profit (EBIT)
₹1,281 cr
₹303 cr
₹82.9 cr
₹1,433 cr
₹1,818 cr
Operating margin
14.8%
3.8%
1.1%
16.4%
20.6%
Interest cost
₹125 cr
₹126 cr
₹106 cr
₹94.4 cr
₹90.7 cr
Profit before tax
₹1,228 cr
₹553 cr
₹200 cr
₹1,543 cr
₹1,835 cr
Tax expense
₹314 cr
₹118 cr
-₹21.6 cr
₹353 cr
₹408 cr
Effective tax rate
25.6%
21.3%
-10.8%
22.9%
22.2%
Net profit (PAT)
₹925 cr
₹444 cr
₹221 cr
₹1,210 cr
₹1,437 cr
Net profit margin
10.7%
5.5%
2.9%
13.9%
16.3%
Basic EPS
₹11.11
₹5.32
₹2.65
₹14.53
—
Diluted EPS
₹11.10
₹5.32
₹2.65
₹14.52
—
DRREDDY results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter
Growth
Q2 FY27
Q1 FY27
Q4 FY26
Q3 FY26
Q2 FY26
Revenue YoY
-1.5%
—
—
—
—
Revenue QoQ
+7.4%
+7.4%
-13.9%
-0.9%
—
Operating profit YoY
-29.5%
—
—
—
—
Operating profit QoQ
+322.2%
+265.9%
-94.2%
-21.2%
—
Net profit YoY
-35.6%
—
—
—
—
Net profit QoQ
+108.6%
+100.8%
-81.7%
-15.8%
—
EPS YoY
—
—
—
—
—
EPS QoQ
+108.8%
+100.8%
-81.8%
—
—
DRREDDY annual results history
Full-year performance for DR. REDDY S LABORATORIES, useful for reading each quarter in context.
DR. REDDY S LABORATORIES annual income statement
Particulars
FY262026-03-31
FY252025-03-31
FY242024-03-31
FY232023-03-31
Revenue / Sales
₹33,593 cr
₹32,554 cr
₹27,916 cr
₹24,588 cr
Total expenses
₹28,581 cr
₹25,352 cr
₹21,386 cr
₹18,683 cr
Gross profit
₹17,726 cr
₹19,043 cr
₹16,361 cr
₹13,934 cr
Operating profit (EBIT)
₹5,012 cr
₹7,201 cr
₹6,531 cr
₹5,905 cr
Operating margin
14.9%
22.1%
23.4%
24.0%
Interest cost
₹374 cr
₹283 cr
₹171 cr
₹143 cr
Profit before tax
₹5,482 cr
₹7,678 cr
₹7,187 cr
₹6,037 cr
Tax expense
₹1,235 cr
₹1,954 cr
₹1,619 cr
₹1,530 cr
Effective tax rate
22.5%
25.4%
22.5%
25.3%
Net profit (PAT)
₹4,285 cr
₹5,654 cr
₹5,568 cr
₹4,507 cr
Net profit margin
12.8%
17.4%
19.9%
18.3%
Basic EPS
₹51.48
₹67.88
₹66.93
₹54.28
Diluted EPS
₹51.42
₹67.78
₹66.80
₹54.17
Revenue trend and demand read-through
Topline for Q2 FY27 came in at ₹8,671 cr against ₹8,805 cr in Q2 FY26, and ₹8,071 cr in the preceding Q1 FY27 quarter.
On a sequential basis revenue grew +7.4%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹7,390 cr, or 85.2% of revenue, with operating profit declined -29.5% year on year.
Margins, tax and profitability
Net profit of ₹925 cr works out to a net margin of 10.7% compared with 16.3% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, DR. REDDY S LABORATORIES reported profit before tax of ₹1,228 cr, a tax charge of ₹314 cr (effective rate 25.6%), interest cost of ₹125 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹444 cr in Q1 FY27 to ₹925 cr in Q2 FY27, a change of +108.6%.
Trailing twelve months and annual context
Across the trailing four quarters DR. REDDY S LABORATORIES has generated revenue of ₹32,984 cr and net profit of ₹2,799 cr, a trailing net margin of 8.5%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹33,593 cr with net profit of ₹4,285 cr and EPS of ₹51.48, versus the prior year where revenue grew +3.2% and profit declined -24.2%.
What to watch in the next DRREDDY quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
No next results date is available in the board-meeting calendar. Statement figures update when Yahoo Finance makes them available; this is not an immediate exchange-filing feed.
Financial figures here are supplied through Yahoo Finance fundamentals and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
What were DR. REDDY S LABORATORIES (DRREDDY) Q2 FY27 results?
In Q2 FY27 (quarter ended 30 Sept 2026), DR. REDDY S LABORATORIES reported revenue of ₹8,671 cr and net profit of ₹925 cr, a change of -35.6% year on year on -1.5% revenue growth. EPS stood at ₹11.11.
What is DRREDDY profit margin in Q2 FY27?
DR. REDDY S LABORATORIES posted a net profit margin of 10.7% and an operating margin of 14.8% in Q2 FY27. On a trailing twelve-month basis, revenue is ₹32,984 cr and net profit ₹2,799 cr.
Did DRREDDY results beat the previous quarter?
DR. REDDY S LABORATORIES net profit changed +108.6% quarter on quarter, from ₹444 cr in Q1 FY27 to ₹925 cr in Q2 FY27.
When are DR. REDDY S LABORATORIES (DRREDDY) quarterly results?
DR. REDDY S LABORATORIES has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see DRREDDY latest quarterly results?
Our latest DRREDDY results coverage — "Dr. Reddy's Laboratories Limited Q2 FY27 Results: Net Profit ₹913 cr, Revenue from operations ₹8,698 cr" — breaks down revenue, profit, margins and management commentary.
What is DR. REDDY S LABORATORIES annual revenue and profit?
For FY26, DR. REDDY S LABORATORIES reported full-year revenue of ₹33,593 cr and net profit of ₹4,285 cr, with EPS of ₹51.48.
How many quarterly results has DRREDDY declared recently?
DRREDDY has held 1 recent board meetings for financial results, the last on 23 Oct 2026.
Results dates: NSE board-meeting calendar. Financial figures: Yahoo Finance fundamentals, not a direct exchange filing feed. Last successful data fetch 29 Oct 2026. Figures can be delayed; results change only when the provider publishes them. For information only, not investment advice.